WHITNEY MASHBURN: Open Payments
NPI 1083952485 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 46 payments from 15 companies in 2025. Trend: 2023 $1,099 · 2024 $1,441 · 2025 $1,157
Food & beverage: $1,057Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $239 |
| Lilly USA, LLC | 7 | $206 |
| Janssen Biotech, Inc. | 2 | $124 |
| Regeneron Pharmaceuticals, Inc. | 1 | $78 |
| ABBVIE INC. | 4 | $66 |
| Galderma Laboratories, L.P. | 4 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| LEO Pharma Inc. | 3 | $57 |
| GENZYME CORPORATION | 2 | $52 |
| Organon LLC | 6 | $50 |
Products named: Bimzelx, DUPIXENT, TREMFYA, EBGLYSS, TALTZ, RINVOQ, NEMLUVIO, ADBRY.
Industry payments across OK — which companies pay providers there.
